Cargando…
p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer
The oncogene product epidermal growth factor receptor (EGF-R), the tumour suppressor gene product p53 and anti-p53 antibodies are detectable in the serum of certain cancer patients. Increased levels of some of these products were reported in lung cancer patients after occupational asbestos exposure...
Autores principales: | Schneider, J, Presek, P, Braun, A, Bauer, P, Konietzko, N, Wiesner, B, Woitowitz, H-J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363153/ https://www.ncbi.nlm.nih.gov/pubmed/10471051 http://dx.doi.org/10.1038/sj.bjc.6690632 |
Ejemplares similares
-
Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor
por: Tian, X X, et al.
Publicado: (1999) -
Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies
por: Moch, C, et al.
Publicado: (2001) -
Serum p53 antibodies: predictors of survival in small-cell lung cancer?
por: Murray, P V, et al.
Publicado: (2000) -
Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma
por: Saffroy, R, et al.
Publicado: (1999) -
Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade
por: Wu, C-W, et al.
Publicado: (1999)